Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines.
about
Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.Factors driving inequality in prostate cancer survival: a population based study.Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.Prevalence of incidental prostate cancer: A systematic review of autopsy studies.Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancerProstate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.Audit of rapid access introduction reveals high prevalence of prostate cancer in Western Region.Initial consecutive 125 cases of robotic assisted laparoscopic radical prostatectomy performed in Ireland's first robotic radical prostatectomy centre.Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake.Standardization of assay methods reduces variability of total PSA measurements: an Irish study.The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008-2010.
P2860
Q33786131-34FB6A06-4B2A-4926-BA7B-CDB388CF07B1Q34155974-3372B9E7-478C-4216-8D47-D3F9BDD36930Q35466577-070A90A5-2134-4C10-8E06-DCAB0E0F581FQ36380194-73FBE93D-6317-4CE3-95A1-0B8EE3578F87Q36723934-F7F5089D-D780-4446-9F28-FC40FAB6B5A1Q36897614-58589E47-2FCE-4730-B676-D6716B203DC1Q40100788-6C15B08D-19BA-4C9F-B8BC-82EAD026AF2FQ43581669-03202A79-6E1A-42EB-9D45-EC9892862BA6Q43779129-8731F6DF-BCC5-4392-9782-CE19C135FD38Q43923584-CD52A2AC-5CFA-4CA6-B968-00CAE87F9794Q45419120-34D61571-5085-4F75-8E08-2542230504B5Q47576363-9617FC15-091E-4A2D-9BD9-711E26CF959BQ50561785-51914161-B0B9-4A13-9684-689EF1701E82Q51226070-20CF343C-B98C-401E-A7F7-DF44675AC6ED
P2860
Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Trends in prostate specific an ...... a country without guidelines.
@en
Trends in prostate specific an ...... a country without guidelines.
@nl
type
label
Trends in prostate specific an ...... a country without guidelines.
@en
Trends in prostate specific an ...... a country without guidelines.
@nl
prefLabel
Trends in prostate specific an ...... a country without guidelines.
@en
Trends in prostate specific an ...... a country without guidelines.
@nl
P2093
P1476
Trends in prostate specific an ...... a country without guidelines.
@en
P2093
P2860
P2888
P356
10.1007/S11845-009-0376-7
P577
2009-06-27T00:00:00Z